SMOC1 and COVID-19: Aside from our own study [2], others have also compared Alzheimer’s disease and COVID-19 transcriptomes and found shared dysregulations in innate immune pathways, including IFITM and OAS family genes both in neuropathological studies and murine models [18,73].